|
1
|
Yancik R and Ries LA: Cancer in older
persons: An international issue in an aging world. Semin Oncol.
31:128–136. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Flowers CR, Sinha R and Vose JM: Improving
outcomes for patients with diffuse large B-cell lymphoma. CA Cancer
J Clin. 60:393–408. 2010.PubMed/NCBI
|
|
3
|
Freeman C, Berg JW and Cutler SJ:
Occurrence and prognosis of extranodal lymphomas. Cancer.
29:252–260. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bourdeanu L, Menon R and Somlo G: Diffuse
large B-cell lymphoma with calf muscle localization. Case Rep
Hematol. 2011:2924942011.PubMed/NCBI
|
|
5
|
Lee VS, Martinez S and Coleman RE: Primary
muscle lymphoma: Clinical and imaging findings. Radiology.
203:237–244. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Talaulikar D, Shadbolt B, Dahlstrom JE and
McDonald A: Routine use of ancillary investigations in staging
diffuse large B-cell lymphoma improves the International Prognostic
Index (IPI). J Hematol Oncol. 2:492009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kandel RA, Bédard YC, Pritzker KP and Luk
SC: Lymphoma. Presenting as an intramuscular small cell malignant
tumor. Cancer. 53:1586–1589. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Glass AG, Karnell LH and Menck HR: The
National Cancer Data Base report on non-Hodgkin's lymphoma. Cancer.
80:2311–2320. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Travis WD, Banks PM and Reiman HM: Primary
extranodal soft tissue lymphoma of the extremities. Am J Surg
Pathol. 11:359–366. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suresh S, Saifuddin A and O'Donnell P:
Lymphoma presenting as a musculoskeletal soft tissue mass: MRI
findings in 24 cases. Eur Radiol. 18:2628–2634. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hwang S: Imaging of lymphoma of the
musculoskeletal system. Radiol Clin North Am. 46:379–396. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Damron TA, Le MH, Rooney MT, Vermont A and
Poiesz BJ: Lymphoma presenting as a soft tissue mass. A soft tissue
sarcoma simulator. Clin Orthop Relat Res:221–230. 1999.
|
|
13
|
Chun CW, Jee WH, Park HJ, Kim YJ, Park JM,
Lee SH and Park SH: MRI features of skeletal muscle lymphoma. AJR
Am J Roentgenol. 195:1355–1360. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hwang S: Imaging of lymphoma of the
musculoskeletal system. Magn Reson Imaging Clin N Am. 18:75–93.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kang HJ, Beylergil V, Price AP, Abramson
SJ and Carrasquillo JA: FDG PET/CT detection of intussusception
caused by lymphoma in a pediatric patient. Clin Nucl Med. 39:97–98.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Knowles B and Serpell JW: Extra-nodal
lymphoma presenting as a mimic of soft-tissue sarcoma. ANZ J Surg.
73:26–30. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Coiffier B, Lepage E, Briere J, Herbrecht
R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G,
Gaulard P, et al: CHOP chemotherapy plus rituximab compared with
CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
N Engl J Med. 346:235–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feugier P, Van Hoof A, Sebban C,
Solal-Celigny P, Bouabdallah R, Fermé C, Christian B, Lepage E,
Tilly H, Morschhauser F, et al: Long-term results of the R-CHOP
study in the treatment of elderly patients with diffuse large
B-cell lymphoma: A study by the Groupe d'Etude des Lymphomes de
l'Adulte. J Clin Oncol. 23:4117–4126. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Habermann TM, Weller EA, Morrison VA,
Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI,
Peterson BA, et al: Rituximab-CHOP versus CHOP alone or with
maintenance rituximab in older patients with diffuse large B-cell
lymphoma. J Clin Oncol. 24:3121–3127. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Coiffier B, Thieblemont C, Van Den Neste
E, Lepeu G, Plantier I, Castaigne S, Lefort S, Marit G, Macro M,
Sebban C, et al: Long-term outcome of patients in the LNH-98.5
trial, the first randomized study comparing rituximab-CHOP to
standard CHOP chemotherapy in DLBCL patients: A study by the Groupe
d'Etudes des Lymphomes de l'Adulte. Blood. 116:2040–2045. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Niitsu N: Current treatment strategy of
diffuse large B-cell lymphomas. Int J Hematol. 92:231–237. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Spina M, Balzarotti M, Uziel L, Ferreri
AJ, Fratino L, Magagnoli M, Talamini R, Giacalone A, Ravaioli E,
Chimienti E, et al: Modulated chemotherapy according to modified
comprehensive geriatric assessment in 100 consecutive elderly
patients with diffuse large B-cell lymphoma. Oncologist.
17:838–846. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang Z, Xu Z and Zhou Y: Chemotherapy
alone versus chemotherapy followed by consolidative radiotherapy
for limited-stage aggressive non-Hodgkin's lymphoma: A
meta-analysis of randomized controlled trials. Cancer Radiother.
17:736–743. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dorth JA, Prosnitz LR, Broadwater G,
Beaven AW and Kelsey CR: Radiotherapy dose-response analysis for
diffuse large B-cell lymphoma with a complete response to
chemotherapy. Radiat Oncol. 7:1002012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hou Y, Wang HQ and Ba Y: Rituximab,
gemcitabine, cisplatin, and dexamethasone in patients with
refractory or relapsed aggressive B-cell lymphoma. Med Oncol.
29:2409–2416. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aribi M, Mesli N, Remla N, Sari BE, Taleb
A, Touhami H, Bekadja MA, ZouaouiBenhadji Z, Bouzid K and Meguenni
K: Gemcitabine and treatment of diffuse large B-cell lymphoma in
relapsed or refractory elderly patients: A prospective randomized
trial in Algeria. J Cancer Res Ther. 6:41–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Crump M, Baetz T, Couban S, Belch A,
Marcellus D, HowsonJan K, Imrie K, Myers R, Adams G, Ding K, et al:
Gemcitabine, dexamethasone, and cisplatin in patients with
recurrent or refractory aggressive histology B-cell non-Hodgkin
lymphoma: A Phase II study by the national cancer institute of
Canada clinical trials group (NCIC-CTG). Cancer. 101:1835–1842.
2004. View Article : Google Scholar : PubMed/NCBI
|
